Similarly, patients with COMP expression in the tumor stroma had a median OS of 0.6-year (p = 0.029; Fig. 2C) and a median RFS of 0.5 years, (p = 0.019; Fig. 2D) compared to 2.4 and 7.2 years respectively, in patients with COMP-negative tumor stroma. This evidence concerns the gene COMP and neoplasm.